Market revenue in 2023 | USD 42.1 million |
Market revenue in 2030 | USD 53.5 million |
Growth rate | 3.5% (CAGR from 2023 to 2030) |
Largest segment | Pcr-based diagnostics |
Fastest growing segment | NGS DNA Diagnosis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.64% in 2023. Horizon Databook has segmented the South Africa dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The market in South Africa is driven by a high burden of infectious diseases like HIV and tuberculosis, necessitating advanced diagnostic solutions. Efforts by government and nongovernmental organizations to improve healthcare accessibility, alongside investments in modern diagnostic technologies, play a significant role in market growth.
The growing awareness and significance of newborn screening, a unique technique that allows healthcare workers to detect potential risks to a newborn's health before they become serious, are important factors boosting the country's DNA diagnostics market. Early genetic problem discovery by newborn screening facilitates prompt intervention and therapy. Consequently, the need for advanced DNA diagnostic techniques increases.
Furthermore, physicians can screen for several metabolic and genetic conditions, such as primary congenital hypothyroidism, cystic fibrosis, classic galactosemia, congenital adrenal hyperplasia, and maple syrup urine disease, with a straightforward heel prick test.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account